Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

Chun, Tae-Wook, Carruth, Lucy, Finzi, Diana, Shen, Xuefei, DiGiuseppe, Joseph A., Taylor, Harry, Hermankova, Monika, Chadwick, Karen +7 more·1997·Nature
DOI 10.1038/387183a0

Cited by (1,000)

Items 101–200 of 1,000

  1. HIV rebounds from latently infected cells, rather than from continuing low-level replication
    Béda Joos, Marek Fischer, Herbert Kuster, Satish K. Pillai, Joseph K. Wong, Jürg Böni, Bernard J. Hirschel, Rainer K. Weber, Alexandra Trkola, Huldrych F. Günthard et al. · 2008 · Proceedings of the National Academy of Sciences
  2. Isolation and Characterization of Replication-Competent Human Immunodeficiency Virus Type 1 from a Subset of Elite Suppressors
    Joel N. Blankson, Justin R. Bailey, Seema Madhumal Thayil, Hung‐Chih Yang, Kara G. Lassen, Jun Lai, Shiv K. Gandhi, Janet D'Angelo Siliciano, Thomas M. Williams, Robert F. Siliciano · 2006 · Journal of Virology
  3. Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs
    Mayte Coiras, María Rosa López‐Huertas, Mayte Pérez‐Olmeda, José Alcamı́ · 2009 · Nature Reviews Microbiology
  4. Modeling the within-host dynamics of HIV infection
    Alan S. Perelson, Ruy Miguel Ribeiro · 2013 · BMC Biology
  5. Simian Immunodeficiency Virus Replicates to High Levels in Sooty Mangabeys without Inducing Disease
    M.A. Rey, Jean-Luc Berthier, Marie Claude Bomsel, Yves Chaduc, Luc Montagnier, Ara G. Hovanessian, Lisa A. Chakrabarti · 1998 · Journal of Virology
  6. Eradicating HIV-1 infection: seeking to clear a persistent pathogen
    Nancie M. Archin, Julia Sung, Carolina Garrido, Natalia Soriano-Sarabia, David M. Margolis · 2014 · Nature Reviews Microbiology
  7. HIV Persistence and the Prospect of Long-Term Drug-Free Remissions for HIV-Infected Individuals
    Didier Trono, Carine M. Van Lint, Christine Rouzioux, Eric M. Verdin, Françoise Barré‐Sinoussi, Tae‐Wook Chun, Nicolas Chomont · 2010 · Science
  8. Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption
    Meghan K. Rothenberger, Brandon F. Keele, Stephen W. Wietgrefe, Courtney Vail Fletcher, Gregory J. Beilman, Jeffrey G. Chipman, Alexander Khoruts, Jacob D. Estes, Jodi L. Anderson, Samuel P. Callisto et al. · 2015 · Proceedings of the National Academy of Sciences
  9. HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir
    Tae‐Wook Chun · 2005 · Journal of Clinical Investigation
  10. Dysfunction and infection of freshly isolated blood myeloid and plasmacytoid dendritic cells in patients infected with HIV-1
    Heather Donaghy, Brian Gazzard, Frances M. Gotch, Steven Patterson · 2003 · Blood
  11. Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy
    Felipe García, Montserrat Plana, Carmen Vidal, Anna Cruceta, William A. O‚Brien, Giuseppe Pantaleo, Tomàs Pumarola, Teresa Gallart, José M. Miró, José M. Gatell · 1999 · AIDS
  12. Predicting the outcomes of treatment to eradicate the latent reservoir for HIV-1
    Alison L. Hill, Daniel I. S. Rosenbloom, Feng Fu, Martin A. Nowak, Robert F. Siliciano · 2014 · Proceedings of the National Academy of Sciences
  13. Viral Dynamics in HIV-1 Infection
    Diana Finzi, Robert F. Siliciano · 1998 · Cell
  14. Parallel analysis of transcription, integration, and sequence of single HIV-1 proviruses
    Einkauf, Kevin B., Osborn, Matthew R., Gao, Ce, Sun, Weiwei, Sun, Xiaoming, Lian, Xiaodong, Parsons, Elizabeth M., Gladkov, Gregory T., Seiger, Kyra W., Blackmer, Jane E. et al. · 2022 · Cell
  15. Syndecans Serve as Attachment Receptors for Human Immunodeficiency Virus Type 1 on Macrophages
    Andrew C. S. Saphire, Michael D. Bobardt, Zhe Zhang, Guido David, Philippe A. Gallay · 2001 · Journal of Virology
  16. An HIV Vaccine — Evolving Concepts
    Johnston, Margaret I., Fauci, Anthony S. · 2007 · New England Journal of Medicine
  17. BET bromodomain inhibition as a novel strategy for reactivation of HIV-1
    Camellia Banerjee, Nancie M. Archin, Daniel Michaels, Anna C. Belkina, Gerald V. Denis, James E. Bradner, Paola Sebastiani, David M. Margolis, Monty A Montano · 2012 · Journal of Leukocyte Biology
  18. A Novel Assay to Measure the Magnitude of the Inducible Viral Reservoir in HIV-infected Individuals
    Francesco A. Procopio, Rémi Fromentin, Deanna A. Kulpa, Jessica H. Brehm, Anne-Gaelle Bebin-Blackwell, Matthew C. Strain, Douglas D. Richman, Una O’Doherty, Sarah Palmer, Frederick M. Hecht et al. · 2015 · EBioMedicine
  19. Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation
    Hung‐Chih Yang, Sifei Xing, Liang Shan, Karen O’Connell, Jason B. Dinoso, Anding Shen, Yan Zhou, Cynthia K. Shrum, Yefei Han, Jun O. Liu et al. · 2009 · Journal of Clinical Investigation
  20. Progress in the Development of an HIV-1 Vaccine
    Norman L. Letvin · 1998 · Science
  21. Coaxing HIV-1 from resting CD4 T cells
    Loyda Ylisastigui, Nancie M. Archin, Ginger K. Lehrman, Ronald J. Bosch, David M. Margolis · 2004 · AIDS
  22. Heterogeneous clearance rates of long-lived lymphocytes infected with HIV: Intrinsic stability predicts lifelong persistence
    Matthew C. Strain, Huldrych F. Günthard, Diane V. Havlir, C. C. Ignacio, Davey M. Smith, Andrew Brown, Theresa R Macaranas, Ruby Y. Lam, Otto A. Daly, M. Fischer et al. · 2003 · Proceedings of the National Academy of Sciences
  23. Use of Real-Time PCR and Molecular Beacons To Detect Virus Replication in Human Immunodeficiency Virus Type 1-Infected Individuals on Prolonged Effective Antiretroviral Therapy
    Sharon R. Lewin, Marja Vesanen, Leondios G. Kostrikis, Arlene Hurley, M. Duran, L. Zhang, David D. Ho, Martin H. Markowitz · 1999 · Journal of Virology
  24. Cell-Based Measures of Viral Persistence Are Associated With Immune Activation and Programmed Cell Death Protein 1 (PD-1)–Expressing CD4+ T cells
    Hiroyu Hatano, Vivek Jain, Peter W. Hunt, Tzong‐Hae Lee, Elizabeth Sinclair, Tri Do, Rebecca Hoh, Jeffrey N. Martin, J M McCune, Frederick M. Hecht et al. · 2012 · The Journal of Infectious Diseases
  25. Cannabinoids: Therapeutic Use in Clinical Practice
    Cristina Pagano, Giovanna Navarra, Laura Coppola, Giorgio Avilia, Maurizio Bifulco, Chiara Laezza · 2022 · International Journal of Molecular Sciences
  26. Modeling HIV persistence, the latent reservoir, and viral blips
    Libin Rong, Alan S. Perelson · 2009 · Journal of Theoretical Biology
  27. Investigating the Consequences of Interference between Multiple CD8+ T Cell Escape Mutations in Early HIV Infection
    Víctor García, Marcus W. Feldman, Roland R. Regoes · 2016 · PLoS Computational Biology
  28. Simian Immunodeficiency Virus Replicates to High Levels in Naturally Infected African Green Monkeys without Inducing Immunologic or Neurologic Disease
    Suzanne R. Broussard, Silvija I. Staprans, Robert G. White, Evelyn M. Whitehead, Mark B. Feinberg, Jonathan S. Allan · 2001 · Journal of Virology
  29. Identifiability of nonlinear systems with application to HIV/AIDS models
    Xiaohua Xia, Claude H. Moog · 2003 · IEEE Transactions on Automatic Control
  30. HIV reservoirs as obstacles and opportunities for an HIV cure
    Tae‐Wook Chun, Susan L. Moir, Anthony S. Fauci · 2015 · Nature Immunology
  31. Rapid Quantification of the Latent Reservoir for HIV-1 Using a Viral Outgrowth Assay
    Gregory M. Laird, Evelyn E. Eisele, Seyed Alireza Rabi, Jun Lai, Stanley Chioma, Joel N. Blankson, Janet D'Angelo Siliciano, Robert F. Siliciano · 2013 · PLoS Pathogens
  32. Proviruses with identical sequences comprise a large fraction of the replication-competent HIV reservoir
    John K. Bui, Michele D. Sobolewski, Brandon F. Keele, Jonathan Spindler, Andrew Musick, Ann P. Wiegand, Brian T. Luke, Wei Shao, Stephen H. Hughes, John M. Coffin et al. · 2017 · PLoS Pathogens
  33. Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy
    Jan M. Prins, Suzanne Jurriaans, Rieneke M. E. van Praag, Hetty Blaak, Ronald P. van Rij, Peter T. A. Schellekens, Ineke J. M. ten Berge, Sandro L. Yong, Cecil H. Fox, Marijke T.L. Roos et al. · 1999 · AIDS
  34. Latency reversal and viral clearance to cure HIV-1
    David M. Margolis, J. Víctor García, Daria J. Hazuda, Barton F. Haynes · 2016 · Science
  35. Integrase and integration: biochemical activities of HIV-1 integrase
    Olivier Delelis, Kévin Carayon, Ali Saı̈b, Eric Deprez, J.F. Mouscadet · 2008 · Retrovirology
  36. The multifactorial nature of HIV-1 latency
    Kara G. Lassen, Yefei Han, Yan Zhou, Janet D'Angelo Siliciano, Robert F. Siliciano · 2004 · Trends in Molecular Medicine
  37. Molecular Characterization of Preintegration Latency in Human Immunodeficiency Virus Type 1 Infection
    Theodore C. Pierson, Yan Zhou, Tara L. Kieffer, Christian Thomas Ruff, Christopher B. Buck, Robert F. Siliciano · 2002 · Journal of Virology
  38. Quantification of HIV-1 latency reversal in resting CD4 + T cells from patients on suppressive antiretroviral therapy
    Anthony Richard Cillo, Michele D. Sobolewski, Ronald J. Bosch, Elizabeth Fyne, Michael Piatak, John M. Coffin, John W. Mellors · 2014 · Proceedings of the National Academy of Sciences
  39. Establishment of HIV-1 latency in resting CD4 + T cells depends on chemokine-induced changes in the actin cytoskeleton
    Paul U. Cameron, Suha M. Saleh, Georgina B. Sallmann, Ajantha E. Solomon, Fiona Wightman, Vanessa A. Evans, Geneviève Boucher, Elias K. Haddad, Rafick‐Pierre Sékaly, Andrew Nicholas Harman et al. · 2010 · Proceedings of the National Academy of Sciences
  40. Modeling Latently Infected Cell Activation: Viral and Latent Reservoir Persistence, and Viral Blips in HIV-infected Patients on Potent Therapy
    Libin Rong, Alan S. Perelson · 2009 · PLoS Computational Biology
  41. CCR7 ligands CCL19 and CCL21 increase permissiveness of resting memory CD4+ T cells to HIV-1 infection: a novel model of HIV-1 latency
    Suha M. Saleh, Ajantha E. Solomon, Fiona Wightman, Miranda Xhilaga, Paul U. Cameron, Sharon R. Lewin · 2007 · Blood
  42. Bryostatin Modulates Latent HIV-1 Infection via PKC and AMPK Signaling but Inhibits Acute Infection in a Receptor Independent Manner
    Rajeev Mehla, Shalmali Bivalkar-Mehla, Ruonan Zhang, Indhira Handy, Helmut Albrecht, Shailendra Giri, Prakash S. Nagarkatti, Mitzi Nagarkatti, Ashok Chauhan · 2010 · PLoS ONE
  43. Post-treatment control of HIV infection
    Jessica M. Conway, Alan S. Perelson · 2015 · Proceedings of the National Academy of Sciences
  44. Broadly neutralizing anti-HIV-1 monoclonal antibodies in the clinic
    Marina F. Caskey, Florian Klein, Michel C. Nussenzweig · 2019 · Nature Medicine
  45. HIV-1 Actively Replicates in Naive CD4+ T Cells Residing within Human Lymphoid Tissues
    Daniel A. Eckstein, Michael L Penn, Yael D. Korin, Deirdre D. Scripture-Adams, Jerome A. Zack, Jason F. Kreisberg, Mario Roederer, Michael P. Sherman, Peggy S. Chin, Mark A. Goldsmith · 2001 · Immunity
  46. Single-cell characterization and quantification of translation-competent viral reservoirs in treated and untreated HIV infection
    Marion Pardons, Amy E. Baxter, Marta Massanella, Amélie Pagliuzza, Rémi Fromentin, Caroline Dufour, Louise Leyre, Jean‐Pierre Routy, DE Kaufmann, Nicolas Chomont · 2019 · PLoS Pathogens
  47. Both Memory and CD45RA+/CD62L+Naive CD4+T Cells Are Infected in Human Immunodeficiency Virus Type 1-Infected Individuals
    Mario Ostrowski, Tae‐Wook Chun, J. Shawn Justement, Ivette Motola, Michael A. Spinelli, Joseph W. Adelsberger, Linda A. Ehler, Stephanie B. Mizell, Claire W. Hallahan, Anthony S. Fauci · 1999 · Journal of Virology
  48. HIV-1 Drug Resistance Profiles in Children and Adults With Viral Load of <50 Copies/mL Receiving Combination Therapy
    Monika Hermankova · 2001 · JAMA
  49. Reactivation of latent HIV by histone deacetylase inhibitors
    Kotaro Shirakawa, Leonard Chávez, Shweta Hakre, Vincenzo Calvanese, Eric M. Verdin · 2013 · Trends in Microbiology
  50. Orientation-Dependent Regulation of Integrated HIV-1 Expression by Host Gene Transcriptional Readthrough
    Yefei Han, Yijie Brittany Lin, Wenfeng An, Jie Xu, Hung‐Chih Yang, Karen A. O’Connell, Dominic I. Dordai, Jef D. Boeke, Janet D'Angelo Siliciano, Robert F. Siliciano · 2008 · Cell Host & Microbe
  51. HIV-1 Latency in Monocytes/Macrophages
    Amit Kumar, Wasim Abbas, Georges Herbein · 2014 · Viruses
  52. Nuclear Retention of Multiply Spliced HIV-1 RNA in Resting CD4+ T Cells
    Kara G. Lassen, Kasra X. Ramyar, Justin R. Bailey, Yan Zhou, Robert F. Siliciano · 2006 · PLoS Pathogens
  53. Immunologic strategies for HIV-1 remission and eradication
    Dan H. Barouch, Steven G. Deeks · 2014 · Science
  54. HIV Latency Is Established Directly and Early in Both Resting and Activated Primary CD4 T Cells
    Leonard Chávez, Vincenzo Calvanese, Eric M. Verdin · 2015 · PLoS Pathogens
  55. Entry inhibitors in the treatment of HIV-1 infection
    John C. Tilton, Robert W. Doms · 2009 · Antiviral Research
  56. Experimental approaches to the study of HIV-1 latency
    Yefei Han, Megan Wind‐Rotolo, Hung‐Chih Yang, Janet D'Angelo Siliciano, Robert F. Siliciano · 2007 · Nature Reviews Microbiology
  57. A Sensitive, Quantitative Assay for Human Immunodeficiency Virus Type 1 Integration
    Una O’Doherty, William J. Swiggard, Deepa Jeyakumar, David McGain, Michael H. Malim · 2002 · Journal of Virology
  58. Total HIV-1 DNA, a Marker of Viral Reservoir Dynamics with Clinical Implications
    Véronique Avettand-Fènoël, Laurent Hocqueloux, Jade Ghosn, Antoine Chéret, Pierre Frange, Adeline Mélard, Jean‐Paul Viard, Christine Rouzioux · 2016 · Clinical Microbiology Reviews
  59. HMBA Releases P-TEFb from HEXIM1 and 7SK snRNA via PI3K/Akt and Activates HIV Transcription
    Xavier Contreras, Matjaž Barborič, Tina Lenasi, Boris Matija Peterlin · 2007 · PLoS Pathogens
  60. Macrophages archive HIV‐1 virions for dissemination in trans
    Natalia P. Sharova, Catherine Swingler, Mark E. Sharkey, Mario Stevenson · 2005 · The EMBO Journal
  61. Prolonged viral suppression with anti-HIV-1 antibody therapy
    Christian Gaebler, Lilian Nogueira, Elina Stoffel, Thiago Y. Oliveira, Gaëlle Breton, Katrina G. Millard, Martina Turroja, Allison L. Butler, Víctor Ramos, Michael S. Seaman et al. · 2022 · Nature
  62. Human Immunodeficiency Virus Replication and Genotypic Resistance in Blood and Lymph Nodes after a Year of Potent Antiretroviral Therapy
    Huldrych F. Günthard, Joseph K. Wong, Caroline C. Ignacio, John Guatelli, Nanette L. Riggs, Diane V. Havlir, Douglas D. Richman · 1998 · Journal of Virology
  63. Generation of HIV Latency in Humanized BLT Mice
    Paul W. Denton, Rikke Olesen, Shailesh Kumar Choudhary, Nancy M. Archin, Angela R. Wahl, Michael D. Swanson, Morgan Chateau, Tomonori Nochi, John F. Krisko, Rae Ann Spagnuolo et al. · 2011 · Journal of Virology
  64. A Limited Group of Class I Histone Deacetylases Acts To Repress Human Immunodeficiency Virus Type 1 Expression
    Kara S. Keedy, Nancie M. Archin, Adam T. Gates, Amy S. Espeseth, Daria J. Hazuda, David M. Margolis · 2009 · Journal of Virology
  65. Genotypic Analysis of HIV‐1 Drug Resistance at the Limit of Detection: Virus Production without Evolution in Treated Adults with Undetectable HIV Loads
    Tara L. Kieffer, Mariel McKenzie Finucane, Richard E. Nettles, Thomas C. Quinn, Karl W. Broman, Stuart C. Ray, Deborah Persaud, Robert F. Siliciano · 2004 · The Journal of Infectious Diseases
  66. A Pilot Study Assessing the Safety and Latency-Reversing Activity of Disulfiram in HIV-1-Infected Adults on Antiretroviral Therapy
    Adam M. Spivak, Adriana S. Andrade, Evelyn E. Eisele, Rebecca Hoh, Peter Bacchetti, Namandjé N. Bumpus, Fatemeh Emad, Robert W. Buckheit, Elinore F. McCance‐Katz, Jun Lai et al. · 2013 · Clinical Infectious Diseases
  67. Bryostatin-1 for latent virus reactivation in HIV-infected patients on antiretroviral therapy
    Carolina Gutiérrez, Sergio Serrano Villar, Nadia Madrid-Elena, Marı́a Jesús Pérez-Elı́as, María Elena Martín, Coral Barbas, Francisco Javier Rupérez, Eduardo Muñóz, María Ángeles Muñoz‐Fernández, Trevor P. Castor et al. · 2016 · AIDS
  68. Viral reservoirs, residual viremia, and the potential of highly active antiretroviral therapy to eradicate HIV infection
    Lin Shen, Robert F. Siliciano · 2008 · Journal of Allergy and Clinical Immunology
  69. Kinetics of Human Immunodeficiency Virus Type 1 Decay following Entry into Resting CD4 + T Cells
    Yan Zhou, Haili Zhang, Janet D'Angelo Siliciano, Robert F. Siliciano · 2005 · Journal of Virology
  70. Changes in Human Immunodeficiency Virus Type 1 Fitness and Genetic Diversity during Disease Progression
    Ryan M. Troyer, Kalonji R. Collins, Awet Abraha, Erika Fraundorf, Dawn M. Moore, Randall W. Krizan, Zahra Toossi, Robert Colebunders, Mark A. Jensen, James I. Mullins et al. · 2005 · Journal of Virology
  71. Effects of mycophenolic acid on human immunodeficiency virus infection in vitro and in vivo
    Aude G. Chapuis, Gian Paolo Rizzardi, Claudia D’Agostino, Antoine Attinger, Christian Knabenhans, Sylvain Fleury, Hans Acha‐Orbea, Giuseppe Pantaleo · 2000 · Nature Medicine
  72. The replication-competent HIV-1 latent reservoir is primarily established near the time of therapy initiation
    Abrahams, Melissa-Rose, Joseph, Sarah B., Garrett, Nigel, Tyers, Lynn, Moeser, Matthew, Archin, Nancie, Council, Olivia D., Matten, David, Zhou, Shuntai, Doolabh, Deelan et al. · 2019 · Science Translational Medicine
  73. Disulfiram Reactivates Latent HIV-1 in a Bcl-2-Transduced Primary CD4 + T Cell Model without Inducing Global T Cell Activation
    Sifei Xing, C. Korin Bullen, Neeta S. Shroff, Liang Shan, Hung‐Chih Yang, Jordyn L. Manucci, Shridhar Bhat, Hao Zhang, Joseph B. Margolick, Thomas C. Quinn et al. · 2011 · Journal of Virology
  74. Mice Lacking Pituitary Tumor Transforming Gene Show Testicular and Splenic Hypoplasia, Thymic Hyperplasia, Thrombocytopenia, Aberrant Cell Cycle Progression, and Premature Centromere Division
    Zhiyong Wang, Run Yu, Shlomo K. Melmed · 2001 · Molecular Endocrinology
  75. Molecular Characterization, Reactivation, and Depletion of Latent HIV
    David G. Brooks, Dean H. Hamer, Philip A. Arlen, Lianying Gao, Greg Bristol, Christina M. Ramirez, Edward A. Berger, Jerome A. Zack · 2003 · Immunity
  76. Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineage
    Valentin Le Douce, Georges Herbein, Olivier Rohr, Christian Schwartz · 2010 · Retrovirology
  77. Macrophages and HIV infection: therapeutical approaches toward this strategic virus reservoir
    Stefano Aquaro, Raffaele Caliò, Jan M. Balzarini, Maria Concetta Bellocchi, Enrico Garaci, Carlo Federico Perno · 2002 · Antiviral Research
  78. Pegylated Interferon Alfa-2a Monotherapy Results in Suppression of HIV Type 1 Replication and Decreased Cell-Associated HIV DNA Integration
    Livio Azzoni, Andrea S. Foulkes, Emmanouil Papasavvas, Angela M. Mexas, Kenneth Lynn, Karam Mounzer, Pablo Tebas, Jeffrey M. Jacobson, Ian Frank, Michael Paul Busch et al. · 2012 · The Journal of Infectious Diseases
  79. Mutations in thetatGene Are Responsible for Human Immunodeficiency Virus Type 1 Postintegration Latency in the U1 Cell Line
    Stéphane Emiliani, Wolfgang Fischle, Mélanie Ott, Carine M. Van Lint, Carol Ann Amella, Eric M. Verdin · 1998 · Journal of Virology
  80. Cell Cycle Arrest by Vpr in HIV-1 Virions and Insensitivity to Antiretroviral Agents
    Betty Poon, Kathie Grovit‐Ferbas, Sheila A. Stewart, Irvin S. Y. Chen · 1998 · Science
  81. Analysis of Human Immunodeficiency Virus Type 1 Gene Expression in Latently Infected Resting CD4 + T Lymphocytes In Vivo
    Monika Hermankova, Janet D'Angelo Siliciano, Yan Zhou, Daphne Monie, Karen R. Chadwick, Joseph B. Margolick, Thomas C. Quinn, Robert F. Siliciano · 2003 · Journal of Virology
  82. Towards an HIV-1 cure: measuring the latent reservoir
    Katherine M. Bruner, Nina N. Hosmane, Robert F. Siliciano · 2015 · Trends in Microbiology
  83. The Distribution of HIV DNA and RNA in Cell Subsets Differs in Gut and Blood of HIV-Positive Patients on ART: Implications for Viral Persistence
    Steven A. Yukl, Amandeep K. Shergill, Terence N. Ho, Maudi Killian, Valerie Girling, Lorrie Epling, Peilin Li, Lisa Kanata Wong, Pierre-Cédric Crouch, Steven G. Deeks et al. · 2013 · The Journal of Infectious Diseases
  84. Application of CRISPR/Cas9-Based Gene Editing in HIV-1/AIDS Therapy
    Qiaoqiao Xiao, Deyin Guo, Shuliang Chen · 2019 · Frontiers in Cellular and Infection Microbiology
  85. Determinants of HIV-1 reservoir size and long-term dynamics during suppressive ART
    Nadine Bachmann, Chantal von Siebenthal, Valentina Vongrad, Teja Turk, Kathrin Neumann, Niko Beerenwinkel, Jasmina Bogojeska, Jacques Fellay, Volker Röth, Yik Lim Kok et al. · 2019 · Nature Communications
  86. Basics of the virology of HIV-1 and its replication
    Saleta Sierra, Bernd Kupfer, Rolf Kaiser · 2005 · Journal of Clinical Virology
  87. HIV virology and pathogenetic mechanisms of infection: a brief overview
    Emanuele Fanales‐Belasio, Mariangela Raimondo, Barbara Suligoi, Stefano Buttò · 2010 · Annali dell Istituto Superiore di Sanità
  88. Human Immunodeficiency Virus Type 1 Can Establish Latent Infection in Resting CD4<sup>+</sup>T Cells in the Absence of Activating Stimuli
    Swiggard, William J., Baytop, Clifford, Yu, Jianqing J., Dai, Jihong, Li, Chuanzhao, Schretzenmair, Richard, Theodosopoulos, Ted, O'Doherty, Una · 2005 · Journal of Virology
  89. The history of antiretroviral therapy and of its implementation in resource-limited areas of the world
    Stefano Vella, Bernard Schwartländer, Salif Papa Sow, Serge Paul Eholié, Robert L. Murphy · 2012 · AIDS
  90. A pseudovirus system enables deep mutational scanning of the full SARS-CoV-2 spike
    Bernadeta Dadonaite, Katharine H. D. Crawford, Caelan E. Radford, Ariana Ghez Farrell, Timothy C. Yu, William W. Hannon, Pan-Pan Zhou, Raiees Andrabi, Dennis R. Burton, Lihong Liu et al. · 2023 · Cell
  91. A stable latent reservoir for HIV-1 in resting CD4+ T lymphocytes in infected children
    Deborah Persaud, Theodore C. Pierson, Christian Thomas Ruff, Diana Finzi, Karen R. Chadwick, Joseph B. Margolick, Andrea Ruff, Nancy Hutton, Stuart C. Ray, Robert F. Siliciano · 2000 · Journal of Clinical Investigation
  92. Interleukin-7 Induces Expression of Latent Human Immunodeficiency Virus Type 1 with Minimal Effects on T-Cell Phenotype
    Deirdre D. Scripture-Adams, David G. Brooks, Yael D. Korin, Jerome A. Zack · 2002 · Journal of Virology
  93. Novel Single-Cell-Level Phenotypic Assay for Residual Drug Susceptibility and Reduced Replication Capacity of Drug-Resistant Human Immunodeficiency Virus Type 1
    Haili Zhang, Yan Zhou, Cecily Alcock, Tara L. Kieffer, Daphne Monie, Janet D'Angelo Siliciano, Quan Li, Paul A. Pham, Joseph Cofrancesco, Deborah Persaud et al. · 2004 · Journal of Virology
  94. Intrinsic Stability of Episomal Circles Formed during Human Immunodeficiency Virus Type 1 Replication
    Theodore C. Pierson, Tara L. Kieffer, Christian Thomas Ruff, Christopher B. Buck, Stephen J. Gange, Robert F. Siliciano · 2002 · Journal of Virology
  95. The Effect of Commencing Combination Antiretroviral Therapy Soon after Human Immunodeficiency Virus Type 1 Infection on Viral Replication and Antiviral Immune Responses
    Martin H. Markowitz, Mika Vesanen, Klara Tenner‐Racz, Yunzhen Cao, James Μ. Binley, Andrew H. Talal, Arlene Hurley, Xia Ji, Minhal Chaudhry, Melody Yaman et al. · 1999 · The Journal of Infectious Diseases
  96. Multiple Origins of Virus Persistence during Natural Control of HIV Infection
    Eli Boritz, Samuel W. Darko, Luke Swaszek, Gideon S Wolf, David W. Wells, Xiaolin Wu, Amy R. Henry, Farida Laboune, Jianfei Hu, David R. Ambrozak et al. · 2016 · Cell
  97. Transcriptional Reprogramming during Effector-to-Memory Transition Renders CD4+ T Cells Permissive for Latent HIV-1 Infection
    Liang Shan, Kai Deng, Hongbo Gao, Sifei Xing, Adam A. Capoferri, Christine M. Durand, Seyed Alireza Rabi, Gregory M. Laird, Michelle Kim, Nina N. Hosmane et al. · 2017 · Immunity
  98. Generation of HIV latency during thymopoiesis
    David G. Brooks, Scott G. Kitchen, Christina M. Ramirez, Deirdre D. Scripture-Adams, Jerome A. Zack · 2001 · Nature Medicine
  99. Gene expression and viral prodution in latently infected, resting CD4 + T cells in viremic versus aviremic HIV-infected individuals
    Tae‐Wook Chun, J. Shawn Justement, Richard A. Lempicki, Jun Yang, Glynn Dennis, Claire W. Hallahan, Christina Sanford, Punita Pandya, Shuying Liu, Mary E. McLaughlin et al. · 2003 · Proceedings of the National Academy of Sciences
  100. HIV reservoirs: pathogenesis and obstacles to viral eradication and cure
    Chun, Tae-Wook, Fauci, Anthony S. · 2012 · AIDS